Trial Outcomes & Findings for Web Based Tools to Improve Medication Continuity in Adolescents With ADHD (NCT NCT04386096)
NCT ID: NCT04386096
Last Updated: 2022-03-21
Results Overview
This will be calculated based pharmacy dispensing records
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
40 participants
Primary outcome timeframe
An average of 4 months
Results posted on
2022-03-21
Participant Flow
Participant milestones
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
20
|
|
Overall Study
COMPLETED
|
20
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Web Based Tools to Improve Medication Continuity in Adolescents With ADHD
Baseline characteristics by cohort
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
Total
n=40 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
Adolescent
|
13.17 years
STANDARD_DEVIATION 1.28 • n=5 Participants
|
13.49 years
STANDARD_DEVIATION 1.14 • n=7 Participants
|
13.33 years
STANDARD_DEVIATION 1.20 • n=5 Participants
|
|
Age, Continuous
Parent
|
37.14 years
STANDARD_DEVIATION 6.58 • n=5 Participants
|
38.81 years
STANDARD_DEVIATION 7.07 • n=7 Participants
|
37.98 years
STANDARD_DEVIATION 6.79 • n=5 Participants
|
|
Sex: Female, Male
Adolescent · Female
|
6 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Sex: Female, Male
Adolescent · Male
|
14 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
30 Participants
n=5 Participants
|
|
Sex: Female, Male
Parent · Female
|
20 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Sex: Female, Male
Parent · Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Adolescent · Hispanic or Latino
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Adolescent · Not Hispanic or Latino
|
17 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
37 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Adolescent · Unknown or Not Reported
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Parent · Hispanic or Latino
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Parent · Not Hispanic or Latino
|
19 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
39 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Parent · Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Adolescent · American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Adolescent · Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Adolescent · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Adolescent · Black or African American
|
15 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
32 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Adolescent · White
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Adolescent · More than one race
|
3 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Adolescent · Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Parent · American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Parent · Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Parent · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Parent · Black or African American
|
15 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Parent · White
|
4 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Parent · More than one race
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Parent · Unknown or Not Reported
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: An average of 4 monthsThis will be calculated based pharmacy dispensing records
Outcome measures
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Proportion of Days Covered With Medicine
|
0.24 proportion of days covered with medicine
Interval 0.0 to 0.97
|
0 proportion of days covered with medicine
Interval 0.0 to 0.63
|
SECONDARY outcome
Timeframe: An average of 4 monthsPopulation: Data were only collected for the "Mehealth for ADHD software with medication continuity tools" group
Proportion of intervention components completed relative to the components that were recommended by the portal based on adolescent/parent responses to the assessment battery.
Outcome measures
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Fidelity to Intended Use of Intervention Components
|
0.07 Proportion of intervention components
Interval 0.0 to 0.6
|
—
|
SECONDARY outcome
Timeframe: At baseline and approximately 4 months laterPopulation: Missing data for 2 participants in the "Mehealth for ADHD software with no medication continuity tools" group
Adolescent and parent self-report on a 1-5 or 1-7-point scale, depending on the item. Items were re-scaled to a 1 (signifying less belief) to 5 (signifying stronger belief) scale. Individual items measure specific attitudes, subjective norms, and perceived behavioral control. Items were coded so that higher scores aligned with increased perceived advantages of performing the behavior and behavioral control around taking ADHD medicine. We calculated the average score of the total items (Adolescent report = 19 items; Parent report = 17 items). Range of change score is (-4) to (+4).
Outcome measures
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
n=18 Participants
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Change in Pre-intention Factors of Unified Theory of Behavior Change
Adolescent
|
-0.08 score on a scale
Standard Deviation 0.55
|
0.14 score on a scale
Standard Deviation 0.72
|
|
Change in Pre-intention Factors of Unified Theory of Behavior Change
Parent
|
-0.24 score on a scale
Standard Deviation 0.46
|
-0.18 score on a scale
Standard Deviation 0.54
|
SECONDARY outcome
Timeframe: At baseline and approximately 4 months laterPopulation: Missing data for 2 participants in the "Mehealth for ADHD software with no medication continuity tools" group
Adolescent and parent self-report on a 1-7-point scale. Items were re-scaled to a 1 (signifying less intention) to 5 (signifying stronger intention) scale. Items were coded so that higher scores aligned with stronger intention to take ADHD medicine every school day, weekend day, and during school vacations. We calculated the average score of the 3 items. Range of change score is (-4) to (+4).
Outcome measures
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
n=18 Participants
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Change in Intention to Take/Give ADHD Medicine Regularly
Adolescent
|
-0.51 score on a scale
Standard Deviation 1.4
|
-0.01 score on a scale
Standard Deviation 1.43
|
|
Change in Intention to Take/Give ADHD Medicine Regularly
Parent
|
0.03 score on a scale
Standard Deviation 1.19
|
-0.42 score on a scale
Standard Deviation 0.86
|
SECONDARY outcome
Timeframe: At baseline and approximately 4 months laterPopulation: Missing data for 2 participants in the "Mehealth for ADHD software with no medication continuity tools" group
Adolescent self-report on Adolescent Medication Barriers Scale using a 1-5-point Likert Scale. 1 indicates strong agreement and 5 indicates strong disagreement, with higher scores indicating less barriers. Items were coded so that higher scores aligned with increased organizational skills, salience of behavior, and routine around taking ADHD medicine. We calculated the average score of the 8 items. Range of change score is (-4) to (+4).
Outcome measures
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
n=18 Participants
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Change in Adolescent-report of Medication Barriers
|
0.08 score on a scale
Standard Deviation 0.76
|
0.19 score on a scale
Standard Deviation 0.8
|
SECONDARY outcome
Timeframe: At baseline and approximately 4 months laterPopulation: Missing data for 2 participants in the "Mehealth for ADHD software with no medication continuity tools" group. One participant in the "Mehealth for ADHD software with no medication continuity tools" group did not respond to one survey item.
Parent self-report on Parent Medication Barriers Scale using a 1-5-point Likert Scale. 1 indicates strong agreement and 5 indicates strong disagreement, with higher scores indicating less barriers. Items were coded so that higher scores aligned with increased adolescent organizational skills, salience of behavior, and routine around taking ADHD medicine. We calculated the average score of the 9 items. Range of change score is (-4) to (+4).
Outcome measures
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
n=18 Participants
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Change in Parent-report of Medication Barriers
|
-0.11 score on a scale
Standard Deviation 0.5
|
-0.07 score on a scale
Standard Deviation 0.61
|
SECONDARY outcome
Timeframe: At baseline and approximately 4 months laterPopulation: Missing data for 2 participants in the "Mehealth for ADHD software with no medication continuity tools" group
Adolescent self-report of the number of occasions of giving away, trading, or selling ADHD medicine to someone for whom it was not prescribed.
Outcome measures
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
n=18 Participants
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Change in Medication Diversion
|
0 Events
Standard Deviation 0
|
0 Events
Standard Deviation 0
|
SECONDARY outcome
Timeframe: At baseline and approximately 4 months laterPopulation: Missing data for 2 participants in the "Mehealth for ADHD software with no medication continuity tools" group
Adolescent and Parent self-report. The scale contains the following subscales: "Child Seek" (e.g. child asks for an opinion or information from the parent), "Child Express" (e.g. child expresses an opinion or information to the parent), "Parent Seek" (e.g. parent asks for an opinion or information from child), "Parent Express" (e.g. parent expresses advice, an opinion, or information to the child), and "Joint/Options" (e.g. negotiation and brainstorming between child and parent). Each subscale produces a score which ranges from 1 to 4 with higher scores indicating more of that behavior.
Outcome measures
| Measure |
Mehealth for ADHD Software With Medication Continuity Tools
n=20 Participants
Mehealth for ADHD software with medication continuity tools: Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommend tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.
|
Mehealth for ADHD Software With no Medication Continuity Tools
n=18 Participants
Mehealth for ADHD software with no medication continuity tools: The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) an online pediatrician "report card"; and 6) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
|
|---|---|---|
|
Change in Decision Making Involvement Scale
Parent: Parent Express
|
-0.11 score on a scale
Standard Deviation 0.82
|
-0.11 score on a scale
Standard Deviation 0.71
|
|
Change in Decision Making Involvement Scale
Parent: Joint/Options
|
-0.05 score on a scale
Standard Deviation 0.88
|
-0.04 score on a scale
Standard Deviation 0.80
|
|
Change in Decision Making Involvement Scale
Adolescent: Child Seek
|
-0.02 score on a scale
Standard Deviation 1.02
|
-0.02 score on a scale
Standard Deviation 1.20
|
|
Change in Decision Making Involvement Scale
Adolescent: Child Express
|
0 score on a scale
Standard Deviation 1.12
|
0.24 score on a scale
Standard Deviation 1.12
|
|
Change in Decision Making Involvement Scale
Adolescent: Parent Seek
|
0.16 score on a scale
Standard Deviation 0.82
|
0.10 score on a scale
Standard Deviation 1.16
|
|
Change in Decision Making Involvement Scale
Adolescent: Parent Express
|
0.13 score on a scale
Standard Deviation 0.90
|
0.10 score on a scale
Standard Deviation 1.04
|
|
Change in Decision Making Involvement Scale
Adolescent: Joint/Options
|
0.02 score on a scale
Standard Deviation 0.91
|
0.27 score on a scale
Standard Deviation 1.01
|
|
Change in Decision Making Involvement Scale
Parent: Child Seek
|
-0.05 score on a scale
Standard Deviation 0.96
|
-0.07 score on a scale
Standard Deviation 0.85
|
|
Change in Decision Making Involvement Scale
Parent: Child Express
|
-0.07 score on a scale
Standard Deviation 1.02
|
-0.15 score on a scale
Standard Deviation 0.81
|
|
Change in Decision Making Involvement Scale
Parent: Parent Seek
|
-0.10 score on a scale
Standard Deviation 0.66
|
-0.22 score on a scale
Standard Deviation 0.79
|
Adverse Events
Mehealth for ADHD Software With Medication Continuity Tools
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Mehealth for ADHD Software With no Medication Continuity Tools
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place